Alternatively, as APOE4 effects are age-dependent [7, 73], and most clinical studies indicating a higher risk of AD among female APOE4 carriers were conducted in older populations, it is possible that APOE4 effects on ATP usage in women may become evident at older ages. This evidence concerns the gene APOE and Alzheimer disease.